Home
>
National Drug Code (NDC)
>
Iopidine
Iopidine - 0065-0665-05 - (apraclonidine)
Drug Information of Iopidine
| Product NDC: | 0065-0665 |
| Proprietary Name: | Iopidine |
| Non Proprietary Name: | apraclonidine |
| Active Ingredient(s): | 5 mg/mL & nbsp; apraclonidine |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Iopidine
| Product NDC: | 0065-0665 |
| Labeler Name: | Alcon Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020258 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19931001 |
Package Information of Iopidine
| Package NDC: | 0065-0665-05 |
| Package Description: | 5 mL in 1 BOTTLE (0065-0665-05) |
NDC Information of Iopidine
| NDC Code | 0065-0665-05 |
| Proprietary Name | Iopidine |
| Package Description | 5 mL in 1 BOTTLE (0065-0665-05) |
| Product NDC | 0065-0665 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | apraclonidine |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19931001 |
| Marketing Category Name | NDA |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | APRACLONIDINE HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
